@TedOLearyMD@ftrae@javadm20@drjohnm@OmarKreidieh1 These are fair points. Concerning graph nonetheless. PFA lowers the learning curve on much of AF ablation, but not the patient selection, venous access or trans-septal puncture.
@drjohnm The baseline AFEQT (60-ish) is what draws the eye here. It was lower in the SHAM-PVI (50-ish), and PFA SHAM (40-ish) trials - don’t recommend aggressive therapy in mild disease is a valuable tenet.
@HRS_O2Journal@MLloyd_emory Combining FO8 and manual compression into the same category is an either a metholodgical error, or a deliberate decision to favour vascular closure devices. Show us the FO8 vs VCD analysis.
@drjohnm@XavierPrida And there is RCT evidence to back this up for AF - CHESS (2020) for pain, and BEST-AF (2008) for erythema. I will be changing my practice - more juice! The juice is loose!
@sandeep_jalli@MarcPPelletier@DrRajeshMAMC@DrRajeshG1@johnsoncardiol@drrao_TAVI The ORBITA-CTO trial showed 50% of CTO-PCI patients still had angina at 6 months despite anti-anginals. There’s some we can help, but we are poor at identifying them. We need to get better before committing to aggressive strategies that confer no hard end-point improvement.
ECG from NYT story on AI saving a pt.
A highly abnormal ECG. Fragmented wide QRS and first degree av block likely infranodal. Any cardiologist should be able to look at that ECG and predict serious cardiomyopathy.
YOU DON’T NEED AI for this
@HRS_CaseReports@Days88747241 Watch out when leaving this function on immediately following AVN ablation - the device will not pace at the base rate you set overnight, with subsequent drop in HR and increased risk of TdP in the initial weeks after AVNA. Fine to restore function when at target base rate